Cost of revenue decreased 96.7%
Cost of revenue changed -96.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cost of revenue changed -96.7% from the comparable as-filed period.
Current ratio changed -53.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -96.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -100.0% from the comparable as-filed period.
Stockholders' equity changed -102.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.